Article
von Hippel-Lindau disease: Diagnosis and factors influencing disease outcome.
Danish medical journal - 1 Mar 2018
Binderup Marie Louise Mølgaard
Abstract excerpt
von Hippel-Lindau disease (vHL) is a hereditary tumor predisposition caused by mutations in the VHL tumor suppressor gene. VHL mutation-carriers are at life-long risk of multi-organ tumor development. The mainstay of vHL management is close surveillance and surgical tumor removal. The disease has been reported to be fully penetrant at 60 years of age, and has a highly variable phenotype, which complicates vHL...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
